Patents by Inventor Dhanunjay Kumar DOGIPARTI

Dhanunjay Kumar DOGIPARTI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AMORPHOUS PHARMACEUTICAL COMPOSITIONS OF ABIRATERONE ACETATE
    Publication number: 20220387451
    Abstract: The present invention relates to a pharmaceutical composition comprising solid dispersion of amorphous abiraterone acetate and one or more pharmaceutically acceptable excipients, having improved solubility, stability, bioavailability, and no positive food effect. The present invention also relates to a method for its preparation, a dosage form comprising such compositions, and the use of the said composition or dosage form as a medicament for the treatment of prostate cancer.
    Type: Application
    Filed: November 13, 2020
    Publication date: December 8, 2022
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Dhanunjay Kumar DOGIPARTI, Koteshwara MUDIGONDA, Jyothsna RAVULA, Venkateswarlu JASTI
  • PHARMACEUTICAL COMPOSITIONS OF 5-HT6 RECEPTOR ANTAGONIST
    Publication number: 20210346374
    Abstract: The present invention relates to an immediate release (IR) pharmaceutical composition comprising 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl) methyl]-1H-indole or pharmaceutically acceptable salt (s) and one or more pharmaceutically acceptable excipients. The present invention also relates to methods of preparation of said pharmaceutical compositions.
    Type: Application
    Filed: July 16, 2021
    Publication date: November 11, 2021
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Koteshwara MUDIGONDA, Dhanunjay Kumar DOGIPARTI, Venkateswarlu JASTI
  • PHARMACEUTICAL COMPOSITIONS OF 5-HT6 ANTAGONIST
    Publication number: 20190336497
    Abstract: The present invention relates to an immediate release (IR) pharmaceutical composition comprising 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole or pharmaceutically acceptable salt(s) and one or more pharmaceutically acceptable excipients. The present invention also relates to methods of preparation of said pharmaceutical compositions.
    Type: Application
    Filed: September 29, 2017
    Publication date: November 7, 2019
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Koteshwara MUDIGONDA, Dhanunjay Kumar DOGIPARTI, Venkateswarlu JASTI